Project Grant R01EY038669
- Summary of Federal Grant Award The National Eye Institute (NEI) awarded the University of Pittsburgh a $679,650 Project Grant under the Vision Research program (CFDA 93.867) effective June 1, 2026, through May 31, 2030. The award funds research to develop and validate adaptive optics ophthalmoscopy (AOO) as a non-invasive, label-free imaging tool for real-time assessment of immune responses in posterior uveitis, an inflammatory eye condition responsible for up to 10% of blindness in the United...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded $830,024 to The Regents of the University of Colorado under the Vision Research program (CFDA 93.867) for a two-year project spanning September 1, 2025, through August 31, 2027. The project, titled "Elucidating Competence and Fate Choice Dynamics During Retinal Development," focuses on understanding the mechanisms by which retinal progenitor cells differentiate into seven major cell types during development. The...
- Federal Project Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded $287,457 to the University of California, Davis on July 1, 2026, to support a K23 career development project focused on personalized prediction of treatment response and outcomes in patients with non-infectious uveitis (NIU). The project, extending through March 31, 2031, will deliver machine learning (ML) predictive models designed to guide personalized treatment...
- Federal Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded the Regents of the University of Michigan a $1.43 million Project Grant (awarded August 1, 2025; completion date March 31, 2030) to conduct a pragmatic randomized clinical trial testing technology-based glaucoma and eye disease screening in Federally Qualified Health Centers (FQHCs). The research addresses a critical public health need: while glaucoma is treatable, only half...
- Federal Project Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded a $733,137 Project Grant to the University of California, Los Angeles on September 15, 2025, with a completion date of March 31, 2030. This award funds research investigating how genetic variation influences disease progression and therapeutic response in age-related macular degeneration (AMD), a leading cause of vision loss in older adults. The project integrates...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded the University of California, Los Angeles a $722,904 Project Grant effective May 1, 2026, through April 30, 2031, under the Vision Research program (CFDA 93.867). The grant supports the ROBUST (Researching OCT Biomarkers in Uveitis Clinical Trials) project, which conducts secondary analysis of optical coherence tomography (OCT) imaging and clinical datasets from four NEI-funded uveitis randomized clinical trials. The project...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded Boston Children's Hospital a $489,500 Project Grant under the Vision Research program (CFDA 93.867) for the period July 1, 2026 through June 30, 2028. The award supports research assessing neuronal and glial contributions to autosomal dominant optic atrophy (ADOA), a progressive neurodegenerative disorder characterized by retinal ganglion cell degeneration and vision loss. The project will deliver mechanistic insights into ADOA...
- Federal Grant Award Summary Northeastern University received a $1.93 million Project Grant from the National Eye Institute under the Vision Research program (CFDA 93.867), awarded September 1, 2025, with completion targeted for April 30, 2030. The award funds development of an open-source extended-reality (XR) platform designed to democratize access to vision science assessments and interventions for individuals with low vision and visual impairment. The platform integrates high-resolution...
- Federal Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded a $3.0 million Project Grant to the Doheny Eye Institute for research on the mechanobiology of retinal vascular inflammation and degeneration in diabetes. Commencing September 1, 2025, and concluding August 31, 2028, this grant funds fundamental and translational research investigating how mechanical stiffening of retinal blood vessels contributes to early-stage diabetic...
- Federal Project Grant Award Summary Massachusetts Eye and Ear Infirmary received a $467,277 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective July 1, 2026 through June 30, 2028. The award funds the development and validation of a clinical testing battery designed to characterize the visuoperceptual profile of children with Cerebral (Cortical) Visual Impairment (CVI) compared to neurotypically developing controls. CVI, the leading cause...
The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded a $315,000 Project Grant to the University of Colorado-Denver effective July 1, 2026, through April 30, 2030. The award funds development of a multidisciplinary telemedicine care model designed to address critical gaps in chronic pediatric uveitis management and improve access to specialized care for affected children and families. The project will deliver remote clinical services from pediatric ophthalmologists, uveitis specialists, and pediatric rheumatologists, supported by local technicians who collect health data and imaging. The telemedicine infrastructure will reduce travel burdens for families in underserved and remote areas while enabling improved long-term monitoring of a rare, vision-threatening disease that frequently results in serious complications including cataracts, glaucoma, retinal damage, and blindness when inadequately managed. Complementing clinical service delivery, the project will provide coordinated psychosocial support through virtual collaboration with social workers, psychologists, and parent support groups to address emotional and quality-of-life challenges for pediatric patients and their families. A community advisory group comprising caregivers, healthcare providers, social workers, advocacy organizations, and professional societies will guide model development and implementation, ensuring responsiveness to stakeholder needs. This multidisciplinary, technology-enabled approach directly supports NEI's mission to eliminate vision loss and improve quality of life through innovative research and clinical models that expand opportunities for affected populations.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $315.0k | 7/1/26 |